Myriad Decision: Praise and Perils for Biotechnology Patent Policy – PharmExec.com (blog)
By Dr. Matthew Watson
 The Hindu | Myriad Decision: Praise and Perils for Biotechnology Patent Policy PharmExec.com (blog) The Supreme Court decision blocking patents on naturally-occurring genes has generated predictions of doom for biotech innovation, along with expectations of more healthy competition in discovering new treatments and diagnostics. Although some ... Biotech loves Supreme Court ruling on gene patentsCBS News US Supreme Court issues mixed ruling on DNA patentsThe Pharma Letter Supreme Court gene patent threat to CambridgeBusiness Weekly MarketWatch -Chicago Tribune -South China Morning Post all 888 news articles » |
Uncategorized
Comments Off on Myriad Decision: Praise and Perils for Biotechnology Patent Policy – PharmExec.com (blog) |
June 16th, 2013
This author published 5872 posts in this site.Share
Comments are closed.
Personalized Gene Medicine
| Mesenchymal Stem Cells
| Stem Cell Treatment for Multiple Sclerosis
| Stem Cell Treatments
| Board Certified Stem Cell Doctors
| Stem Cell Medicine
| Personalized Stem Cells Therapy
| Stem Cell Therapy TV
| Individual Stem Cell Therapy
| Stem Cell Therapy Updates
| MD Supervised Stem Cell Therapy
| IPS Stem Cell Org
| IPS Stem Cell Net
| Genetic Medicine
| Gene Medicine
| Longevity Medicine
| Immortality Medicine
| Nano Medicine
| Gene Therapy MD
| Individual Gene Therapy
| Affordable Stem Cell Therapy
| Affordable Stem Cells
| Stem Cells Research
| Stem Cell Breaking Research